Allam, who served as the CEO at the Public Investment Fund prior to joining Cadila Pharmaceuticals, will report to Group Chairman and Managing Director Rajiv Modi, the company said in a statement. Previously he has worked with multinationals such as Johnson & Johnson, Amgen, Eli Lilly, BMS and Mundipharma, it added.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qO0oujt
via IFTTT
0 comments:
Post a Comment